Home | PRMA Insights | Scope of publicationprmainsights

PRMA Insights: The Roadmap to Pricing and Reimbursement Success

Each publication delivers The scope of each publication Who should read PRMA Insights Reasons to buy
NSCLC Psoriasis Metastatic Breast Cancer Type 2 Diabetes Renal Cell Carcinoma COPD Oncology products with companion diagnostics Rheumatoid arthritis Non-Hodgkin's lymphoma flyer
prmaconsulting prmavirtual

The scope of each publication

Comprehensive secondary research, experienced based insight and validation by payers and Key Opinion Leaders (KOLs) across markets underpins PRMA Insights: The Roadmap to Pricing and Reimbursement Success:

  1. Reporting of the regulatory nominations and key supporting data for the major targeted therapies.

  2. The current pricing and reimbursement landscape for each disease in the Top 7 major pharmaceutical markets:

    US
    Spain
    UK
    Italy
    France
    Japan
    Germany
  3. Reviews of the clinical guidelines for each disease area including:

    ASCO
    Japanese Lung Cancer Society
    NCCN
    National Medical Societies
    ESMO  
  4. The comprehensive review and assessment of all pricing and reimbursement and HTA decisions for targeted therapies and all relevant chemotherapeutic backbones across all lines of therapy.

  5. The assessments of Health Technology Assessments (HTA) and pricing and reimbursement decisions recently made in each disease area by the following bodies:

    AIFA
    G-BA
    NICE
    CEPS
    INEK
    SMC
    CMS
    IQWIG
    TC
    DGFPS
    MHLW
    UVEF

To find out more or register your disease area interest, click here

Fill in the fields below and press submit. A member of our team
will respond shortly.

prmainsights
Tel: +44 (0) 1252 624429 Email: info@prmainsights.comTerms & ConditionsPrivacy Policy